Spiriva

Federal health regulators say recent data do not show a connection between a popular respiratory inhaler and previously reported risks of stroke, heart attack and death.The US Food and Drug Administration announced that data from a recent review of the Spiriva HandiHaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease , do not support an increased risk of stroke, ...The FDA began investigating Spiriva's safety last March after Boehringer reported slightly higher rates of stroke and heart attack for patients using its device, compared with a placebo. The FDA now says a recent review of a ...Spiriva is approved to treat chronic obstructive pulmonary disease, which includes chronic bronchitis and emphysema. The product is a maintenance therapy … Leading COPD Drug Won't Harm Heart: FDABusinessWeek ...http://www.mochila.com/article_powered_by_mochila.html?articleId=66917073&buyerId=Antiwarcom&channelId=1573. MIKEBREAK. Federal health regulators say recent data do not show a connection between a popular respiratory inhaler and ...

Spiriva , a medication that is sometimes recommended in the treatment of COPD, affords patients 24-hour improved lung function.US FDA sees no link to risks with Pfizer's Spiriva Reuters - 49 minutes ago WASHINGTON, Jan 14 - US health officials on Thursday said they found no increased risk of heart trouble with use of Pfizer Inc's (PFE. ...The FDA has found no association between tiotropium, used in Boehringer Ingelheim's Spiriva HandiHaler, and an increased risk for certain serious cardiovascular events.